for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Shilpa Medicare Launches Indian Branded Generic Of Anti-Cancer Drug Ibrutinib

May 28 (Reuters) - Shilpa Medicare Ltd:

* LAUNCHES INDIAN BRANDED GENERIC OF ANTI-CANCER DRUG IBRUTINIB, WITH BRAND NAME IBRUSHIL

* IBRUSHIL MONTHLY THERAPY COST WILL BE 34,920 RUPEES Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up